<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Six children with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> underwent allogeneic bone marrow transplantation (BMT) from their HLA-identical siblings </plain></SENT>
<SENT sid="1" pm="."><plain>Ages ranged from six to 16 years </plain></SENT>
<SENT sid="2" pm="."><plain>French-American British (FAB) diagnosis was <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) in three, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) in one and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) in two cases </plain></SENT>
<SENT sid="3" pm="."><plain>Two patients had progressed to <z:hpo ids='HP_0001909'>leukemia</z:hpo> before BMT </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received <z:chebi fb="0" ids="28901">busulfan</z:chebi> and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> as a conditioning regimen </plain></SENT>
<SENT sid="5" pm="."><plain>Antithymocyte globulin (ATG) was administered to two of them due to the multiple transfusion history </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">Graft versus host disease</z:e> (GvHD) prophylaxis consisted of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>-<z:chebi fb="0" ids="44185">methotrexate</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Engraftment was documented in <z:hpo ids='HP_0000001'>all</z:hpo> patients except one who underwent a second infusion of bone marrow cells </plain></SENT>
<SENT sid="8" pm="."><plain>She died in the early post-transplant period with <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> and <z:e sem="disease" ids="C0019156" disease_type="Disease or Syndrome" abbrv="">veno-occlusive disease of the liver</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Two patients died from disease recurrence </plain></SENT>
<SENT sid="10" pm="."><plain>Three patients are alive &gt; 12 months post-transplant, two are in remission and one just relapsed at +16 months and is now being prepared for a second bone marrow transplant </plain></SENT>
<SENT sid="11" pm="."><plain>The only significant factor for favorable outcome was short duration between diagnosis to transplant in the two patients in remission </plain></SENT>
</text></document>